Zhang Lab
Research
Research Directions


Systems Biology 系统生物学

在后基因组时代,我们面临的一个重大挑战是解析遗传变异与环境的相互作用如何塑造基因表达的调控以及基因调控在个体间的差异如何影响疫苗免疫应答、疾病发生等人类复杂性状。而解析基因表达的调控机制,则需要系统地结合分子生物学、遗传学、统计学的研究方法。我们是一个跨计算生物学和实验生物学以及生物技术的多元交叉学科团队。我们通过和医院、疫苗企业等单位积极合作,将基因组技术、免疫学手段等运用于临床样本,开展基于临床问题的免疫全景、多组学研究。
In the post-genomic era, a major challenge we face is deciphering how the interaction between genetic variation and environmental factors shapes gene expression regulation, and how interindividual differences in gene regulation impact complex human traits such as vaccine immune responses and disease susceptibility. Understanding the mechanisms underlying gene expression regulation requires a systematic integration of molecular biology, genetics, and statistical approaches. Our team is a multidisciplinary group bridging computational biology, experimental biology, and biotechnology. Through active collaboration with hospitals, vaccine companies, and other institutions, we apply genomic technologies and immunological approaches to clinical samples, conducting immunological and multi-omics research based on clinical questions.

Systems Vaccinology 系统疫苗学

    我们致力于使用系统生物学研究范式解析疫苗免疫应答在人群中的多样性及其调控机制。疫苗是人类对抗感染性疾病最为经济有效的工具,新型疫苗技术与免疫学的发展,使得疫苗在肿瘤的免疫治疗方面也开始崭露头角。然而,在过去很长一段时间里,我们的疫苗发展总体上依赖于经验型研究;我们对疫苗与免疫系统的相互作用机制目前仍知之甚少。因此,我们致力于理解疫苗免疫应答的作用规律,并最终利用这些规律根据人群遗传和免疫特征、疫苗技术特点等参数规划免疫策略以及设计靶向免疫应答机制的新一代更安全更高效的疫苗

We are dedicated to utilizing systems biology paradigms to elucidate the  regulatory mechanisms of diverse vaccine immune responses in populations. Vaccines is the most cost-effective tool for combating infectious diseases, and advancements in novel vaccine technologies and immunology have begun to highlight their potential in novel therapeutic potential such as cancer immunotherapy. However, for a long time, vaccine development has predominantly relied on empirical research; our understanding of the mechanisms underlying the interactions between vaccines and the immune system remains limited. Therefore, we are committed to understand the principles governing vaccine immune responses and ultimately leveraging these principles to design next-generation vaccines targeting genetic- and immune-mediated immune response mechanisms to achieve better safety and effectiveness in a wider range of people.

Grants
云南省科技厅重大科技(生物医药)专项  202102AA100051,项目主持,1195 万元                                 2021-2024
国家重点研发计划  2023YFC2307600,项目主持,1200 万元                                                                    2023-2026
昆明市“春城计划”  2022SCP001,子课题,350 万元                                                                                   2023-2027
云南省兴滇人才青年项目,项目主持,100万元                                                                                              2022-2026